Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 930

1.

[Patent foramen ovale-intervention or pharmaceutical treatment].

Liebetrau C, Hamm CW.

Internist (Berl). 2018 Jul 5. doi: 10.1007/s00108-018-0459-5. [Epub ahead of print] Review. German.

PMID:
29978350
2.

The effect of prehospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis.

Collet JP, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm CW, Van 't Hof AW, Montalescot G; ATLANTIC Investigators.

EuroIntervention. 2018 Jul 3. pii: EIJ-D-18-00182. doi: 10.4244/EIJ-D-18-00182. [Epub ahead of print]

3.

Transcatheter aortic valve implantation in Germany.

Kim WK, Hamm CW.

Clin Res Cardiol. 2018 Jun 27. doi: 10.1007/s00392-018-1297-0. [Epub ahead of print] Review.

PMID:
29951801
4.

Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.

Wiedenroth CB, Ghofrani HA, Adameit MSD, Breithecker A, Haas M, Kriechbaum S, Rieth A, Hamm CW, Mayer E, Guth S, Liebetrau C.

Pulm Circ. 2018 Jul-Sep;8(3):2045894018783996. doi: 10.1177/2045894018783996.

PMID:
29939102
5.

Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.

Olivier CB, Sundaram V, Bhatt DL, Leonardi S, Lopes RD, Ding VY, Yang L, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, White HD, Desai M, Lynch DR Jr, Harrington RA, Mahaffey KW; CHAMPION PLATFORM and CHAMPION PCI Investigators.

Int J Cardiol. 2018 Jun 8. pii: S0167-5273(17)38082-8. doi: 10.1016/j.ijcard.2018.06.034. [Epub ahead of print]

PMID:
29937301
6.

Branched-chain Amino Acids are associated with Metabolic Parameters in Bipolar Disorder.

Fellendorf FT, Platzer M, Pilz R, Rieger A, Kapfhammer HP, Mangge H, Dalkner N, Zelzer S, Meinitzer A, Birner A, Bengesser SA, Queissner R, Hamm C, Hartleb R, Reininghaus EZ.

World J Biol Psychiatry. 2018 Jun 14:1-13. doi: 10.1080/15622975.2018.1487077. [Epub ahead of print]

PMID:
29898625
7.

Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Sommer T, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Jun 12. doi: 10.1002/clc.22996. [Epub ahead of print]

8.

Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation.

Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, Kuniss M, Neumann T.

Int J Cardiol. 2018 Sep 1;266:106-111. doi: 10.1016/j.ijcard.2018.03.069.

PMID:
29887425
9.

Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.

Liebetrau C, Gaede L, Kim WK, Arsalan M, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Kriechbaum S, Huber MT, van Linden A, Berkowitsch A, Dörr O, Nef H, Hamm CW, Walther T, Möllmann H.

Int J Cardiol. 2018 Aug 15;265:40-46. doi: 10.1016/j.ijcard.2018.02.037.

PMID:
29885699
10.

Endoplasmic reticulum stress in bipolar disorder? - BiP and CHOP gene expression- and XBP1 splicing analysis in peripheral blood.

Bengesser SA, Reininghaus EZ, Dalkner N, Birner A, Hohenberger H, Queissner R, Fellendorf F, Platzer M, Pilz R, Hamm C, Rieger A, Kapfhammer HP, Mangge H, Reininghaus B, Meier-Allard N, Stracke A, Fuchs R, Holasek S.

Psychoneuroendocrinology. 2018 May 21;95:113-119. doi: 10.1016/j.psyneuen.2018.05.029. [Epub ahead of print]

PMID:
29843019
11.

The ACURATE Neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome.

Kim WK, Möllmann H, Liebetrau C, Renker M, Rolf A, Simon P, Van Linden A, Arsalan M, Doss M, Hamm CW, Walther T.

JACC Cardiovasc Interv. 2018 May 21. pii: S1936-8798(18)31024-0. doi: 10.1016/j.jcin.2018.04.039. [Epub ahead of print]

PMID:
29803694
12.

Accuracy of device landing zone calcium volume measurement with contrast-enhanced multidetector computed tomography.

Kim WK, Renker M, Rolf A, Liebetrau C, Van Linden A, Arsalan M, Doss M, Rieck J, Opolski MP, Möllmann H, Walther T, Hamm CW.

Int J Cardiol. 2018 Jul 15;263:171-176. doi: 10.1016/j.ijcard.2018.02.042.

PMID:
29754916
13.

Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation.

Reininghaus B, Riedrich K, Dalkner N, Bengesser SA, Birner A, Platzer M, Hamm C, Gostner JM, Fuchs D, Reininghaus EZ.

Psychoneuroendocrinology. 2018 Aug;94:25-30. doi: 10.1016/j.psyneuen.2018.04.029. Epub 2018 May 6.

PMID:
29753175
14.

Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block.

Weipert KF, Bogossian H, Conzen P, Frommeyer G, Gemein C, Helmig I, Chasan R, Eckardt L, Seyfarth M, Lemke B, Zarse M, Hamm CW, Schmitt J, Erkapic D.

Clin Res Cardiol. 2018 May 11. doi: 10.1007/s00392-018-1275-6. [Epub ahead of print]

PMID:
29752526
15.

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.

Bergmark BA, Udell JA, Morrow DA, Cannon CP, Steen DL, Jarolim P, Budaj A, Hamm C, Guo J, Im K, Kuder JF, Braunwald E, Sabatine MS, O'Donoghue ML.

JAMA Cardiol. 2018 Jun 1;3(6):473-480. doi: 10.1001/jamacardio.2018.0653.

PMID:
29710336
16.

Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.

Beygui F, Van Belle E, Ecollan P, Machecourt J, Hamm CW, Lopez De Sa E, Flather M, Verheugt FWA, Vicaut E, Zannad F, Pitt B, Montalescot G.

Heart. 2018 Apr 25. pii: heartjnl-2018-312950. doi: 10.1136/heartjnl-2018-312950. [Epub ahead of print]

PMID:
29695512
17.

Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Tabert H, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.

18.

Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy.

Wöhrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Münzel T, Schneider S, Markovic S, Seeger J, Rottbauer W, Pfannebecker T, Richardt G, Zahn R, Gori T, Kastner J, Schmermund A, Hamm CW; GABI-R Study Group.

Coron Artery Dis. 2018 Aug;29(5):389-396. doi: 10.1097/MCA.0000000000000618.

PMID:
29649071
19.

Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).

Groves EM, Bhatt DL, Steg PG, Deliargyris EN, Stone GW, Gibson CM, Hamm CW, Mahaffey KW, White HD, Angiolillo D, Prats J, Harrington RA, Price MJ.

Circ Cardiovasc Interv. 2018 Apr;11(4):e005635. doi: 10.1161/CIRCINTERVENTIONS.117.005635.

PMID:
29632238
20.

Rapid Deployment Versus Conventional Bioprosthetic Valve Replacement for Aortic Stenosis.

Ensminger S, Fujita B, Bauer T, Möllmann H, Beckmann A, Bekeredjian R, Bleiziffer S, Landwehr S, Hamm CW, Mohr FW, Katus HA, Harringer W, Walther T, Frerker C; GARY Executive Board.

J Am Coll Cardiol. 2018 Apr 3;71(13):1417-1428. doi: 10.1016/j.jacc.2018.01.065.

PMID:
29598861
21.

Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: Two-year outcome and predictors of recurrence after a single procedure.

Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, Neumann T, Kuniss M.

Int J Cardiol. 2018 May 15;259:76-81. doi: 10.1016/j.ijcard.2017.11.011.

PMID:
29579615
22.

Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry.

Husser O, Fujita B, Hengstenberg C, Frerker C, Beckmann A, Möllmann H, Walther T, Bekeredjian R, Böhm M, Pellegrini C, Bleiziffer S, Lange R, Mohr F, Hamm CW, Bauer T, Ensminger S; GARY Executive Board.

JACC Cardiovasc Interv. 2018 Mar 26;11(6):567-578. doi: 10.1016/j.jcin.2017.12.019.

PMID:
29566803
23.

Bilateral retinoschisis in a dog: A veterinary clinical application for optical coherence tomography.

Schaefer EAF, Whiting REH, Pearce JW, Grahn BH, Hamm CW, Moore CP, Narfström KL.

Vet Ophthalmol. 2018 Mar 8. doi: 10.1111/vop.12557. [Epub ahead of print]

PMID:
29517158
24.

A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study.

Nef H, Wiebe J, Boeder N, Dörr O, Bauer T, Hauptmann KE, Latib A, Colombo A, Fischer D, Rudolph T, Foin N, Richardt G, Hamm C.

Catheter Cardiovasc Interv. 2018 Mar 6. doi: 10.1002/ccd.27550. [Epub ahead of print]

PMID:
29508518
25.

Predictors and outcome of conversion to cardiac surgery during transcatheter aortic valve implantation.

Arsalan M, Kim WK, Van Linden A, Liebetrau C, Pollock BD, Filardo G, Renker M, Möllmann H, Doss M, Fischer-Rasokat U, Skwara A, Hamm CW, Walther T.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):267-272. doi: 10.1093/ejcts/ezy034.

PMID:
29506158
26.

Computed Tomography for Diagnosis and Classification of Bicuspid Aortic Valve Disease in Transcatheter Aortic Valve Replacement.

Kim WK, Gaede L, Husser O, Liebetrau C, Renker M, Rolf A, Fischer-Rasokat U, Möllmann S, Blumenstein J, Guenther E, Van Linden A, Arsalan M, Doss M, Loders S, Arnold M, Hamm CW, Walther T, Achenbach S, Möllmann H.

JACC Cardiovasc Imaging. 2018 Feb 9. pii: S1936-878X(18)30002-0. doi: 10.1016/j.jcmg.2017.12.010. [Epub ahead of print] No abstract available.

PMID:
29454778
27.

The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.

Queissner R, Pilz R, Dalkner N, Birner A, Bengesser SA, Platzer M, Fellendorf FT, Kainzbauer N, Herzog-Eberhard S, Hamm C, Reininghaus B, Zelzer S, Mangge H, Mansur RB, McIntyre RS, Kapfhammer HP, Reininghaus EZ.

Psychoneuroendocrinology. 2018 Apr;90:61-67. doi: 10.1016/j.psyneuen.2018.01.024. Epub 2018 Feb 3.

PMID:
29433074
28.

Tilt testing and what you should know about it - Experience with 835 consecutive patients with syncope of unknown origin.

Gemein C, Roos M, Wolf A, Hermann N, Kelava A, Chasan R, Weipert K, Helmig I, Bogossian H, Hamm CW, Neumann T, Schmitt J, Erkapic D.

Int J Cardiol. 2018 May 1;258:90-96. doi: 10.1016/j.ijcard.2018.01.102. Epub 2018 Jan 31.

PMID:
29429639
29.

2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL.

Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):110. doi: 10.1016/j.rec.2017.12.013. English, Spanish. No abstract available.

PMID:
29425605
30.

Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study.

Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van't Hof AW, Montalescot G.

Am Heart J. 2018 Feb;196:56-64. doi: 10.1016/j.ahj.2017.10.021. Epub 2017 Nov 4.

PMID:
29421015
31.

Thrombus aspiration and prehospital ticagrelor administration in ST-elevation myocardial infarction: Findings from the ATLANTIC trial.

Kilic S, Fabris E, Van't Hof AWJ, Hamm CW, Lapostolle F, Lassen JF, Tsatsaris A, Diallo A, Vicaut E, Montalescot G; ATLANTIC Investigators.

Am Heart J. 2018 Feb;196:1-8. doi: 10.1016/j.ahj.2017.09.018. Epub 2017 Oct 3.

32.

[2017 ESC/EACTS Guidelines for the management of valvular heart disease].

Baumgartner H, Falk V, Bax JJ, Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Munoz DR, Rosenhek R, Sjögren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL.

Kardiol Pol. 2018;76(1):1-62. doi: 10.5603/KP.2018.0013. Polish. No abstract available.

33.

N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Kriechbaum SD, Wiedenroth CB, Wolter JS, Hütz R, Haas M, Breithecker A, Roller FC, Keller T, Guth S, Rolf A, Hamm CW, Mayer E, Liebetrau C.

J Heart Lung Transplant. 2018 May;37(5):639-646. doi: 10.1016/j.healun.2017.12.006. Epub 2017 Dec 8.

PMID:
29329761
34.

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease.

Wiedenroth CB, Olsson KM, Guth S, Breithecker A, Haas M, Kamp JC, Fuge J, Hinrichs JB, Roller F, Hamm CW, Mayer E, Ghofrani HA, Meyer BC, Liebetrau C.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217753122. doi: 10.1177/2045893217753122. Epub 2017 Dec 28.

35.

Outcome of thrombus aspiration in STEMI patients: a propensity score-adjusted study.

Blumenstein J, Kriechbaum SD, Leick J, Meyer A, Kim WK, Wolter JS, Abu-Samra M, Weipert K, Bayer M, Dörr O, Walther C, Hamm CW, Nef H, Liebetrau C, Möllmann H.

J Thromb Thrombolysis. 2018 Feb;45(2):240-249. doi: 10.1007/s11239-017-1601-2.

PMID:
29274046
36.

Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation.

Bandorski D, Hoeltgen R, Becker N, Padberg W, Bogossian H, Wiedenroth C, Arlt M, Hamm C, Seeger W, Ghofrani HA, Hecker M, Gall H, Mayer K.

Biomed Res Int. 2017;2017:4519796. doi: 10.1155/2017/4519796. Epub 2017 Nov 6.

37.

Is Outpatient Control of Long-Term Non-Invasive Ventilation Feasible in Chronic Obstructive Pulmonary Disease Patients?

Schwarz SB, Callegari J, Hamm C, Windisch W, Magnet FS.

Respiration. 2018;95(3):154-160. doi: 10.1159/000484569. Epub 2017 Dec 12.

PMID:
29232680
38.

Outcome after transvascular transcatheter aortic valve implantation in 2016.

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H.

Eur Heart J. 2018 Feb 21;39(8):667-675. doi: 10.1093/eurheartj/ehx688.

39.

Efficacy and Safety Comparison Between Suberoylanilide Hydroxamic Acid and Mitomycin C in Reducing the Risk of Corneal Haze After PRK Treatment In Vivo.

Anumanthan G, Sharma A, Waggoner M, Hamm CW, Gupta S, Hesemann NP, Mohan RR.

J Refract Surg. 2017 Dec 1;33(12):834-839. doi: 10.3928/1081597X-20170921-02.

PMID:
29227512
40.

Ice or fire? Comparison of second-generation cryoballoon ablation and radiofrequency ablation in patients with symptomatic persistent atrial fibrillation and an enlarged left atrium.

Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, Neumann T, Kuniss M.

J Cardiovasc Electrophysiol. 2018 Mar;29(3):375-384. doi: 10.1111/jce.13402. Epub 2018 Jan 15.

PMID:
29227008
41.

Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial.

Huber K, Ducrocq G, Hamm CW, van 't Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P.

Open Heart. 2017 Nov 28;4(2):e000677. doi: 10.1136/openhrt-2017-000677. eCollection 2017.

42.

Outcomes in elderly and young patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin: Pooled analysis from the EUROMAX and HORIZONS-AMI trials.

Qaderdan K, Vos GA, McAndrew T, Steg PG, Hamm CW, Van't Hof A, Mehran R, Deliargyris EN, Bernstein D, Stone GW, Ten Berg JM.

Am Heart J. 2017 Dec;194:73-82. doi: 10.1016/j.ahj.2017.08.009. Epub 2017 Aug 18.

PMID:
29223437
43.

Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP, Coman IM, Czerny M, Delgado V, Fitzsimons D, Folliguet T, Gaemperli O, Habib G, Harringer W, Haude M, Hindricks G, Katus HA, Knuuti J, Kolh P, Leclercq C, McDonagh TA, Piepoli MF, Pierard LA, Ponikowski P, Rosano GMC, Ruschitzka F, Shlyakhto E, Simpson IA, Sousa-Uva M, Stepinska J, Tarantini G, Tchétché D, Aboyans V.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):832. doi: 10.1093/ejcts/ezx363. No abstract available.

44.

Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients.

Fujita B, Ensminger S, Bauer T, Möllmann H, Beckmann A, Bekeredjian R, Bleiziffer S, Schäfer E, Hamm CW, Mohr FW, Katus HA, Harringer W, Walther T, Frerker C; GARY Executive Board.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):552-559. doi: 10.1093/ejcts/ezx408.

PMID:
29190355
45.

PLAAF score as a novel predictor of long-term outcome after second-generation cryoballoon pulmonary vein isolation.

Akkaya E, Berkowitsch A, Greiss H, Hamm CW, Sperzel J, Neumann T, Kuniss M.

Europace. 2017 Nov 16. doi: 10.1093/europace/eux295. [Epub ahead of print]

PMID:
29161372
46.

2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):616-664. doi: 10.1093/ejcts/ezx324. No abstract available.

47.

Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.

Klingenberg R, Aghlmandi S, Liebetrau C, Räber L, Gencer B, Nanchen D, Carballo D, Akhmedov A, Montecucco F, Zoller S, Brokopp C, Heg D, Jüni P, Marti Soler H, Marques-Vidal PM, Vollenweider P, Dörr O, Rodondi N, Mach F, Windecker S, Landmesser U, von Eckardstein A, Hamm CW, Matter CM, Lüscher TF.

Eur Heart J. 2017 Dec 14;38(47):3493-3502. doi: 10.1093/eurheartj/ehx640.

PMID:
29155984
48.

Second-generation cryoballoon ablation for treatment of persistent atrial fibrillation: Three-year outcome and predictors of recurrence after a single procedure.

Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, Neumann T, Kuniss M.

J Cardiovasc Electrophysiol. 2018 Jan;29(1):38-45. doi: 10.1111/jce.13372. Epub 2017 Nov 10.

PMID:
29064127
49.

[Heart valve disesases : How sufficient is the knowledge of the German population?]

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Hamm C, Elsässer A, Nef H, Möllmann H.

Herz. 2017 Oct 20. doi: 10.1007/s00059-017-4632-8. [Epub ahead of print] German.

PMID:
29052748
50.

The Future of TAVI.

Kim WK, Hamm CW.

Eur Heart J. 2017 Sep 21;38(36):2704-2707. doi: 10.1093/eurheartj/ehx474. No abstract available.

PMID:
29044388

Supplemental Content

Support Center